Laura Harris: Unfiltered

Preclinical data shows GLIX1 can make PARP inhibitors effective in previously unresponsive tumors, a potential game-changer for 50% of ovarian cancer patients.

With a new mega-fund on the horizon, Antin Infrastructure Partners' latest senior promotions in London signal a strategic play in a hyper-competitive market.

Boston-based Assail launches Sidewinder, an AI that autonomously finds exploits, fixes its own mistakes, and learns. Is this the end of traditional pentesting?

dxFeed and Overcharts are giving retail traders access to institutional-grade options data, a move that signals a major shift in the fintech data wars.

HMNC Brain Health's new oral ketamine shows promise by minimizing side effects, but an unmet endpoint raises questions. Is this the key to at-home TRD care?

With an $85M commitment, Dundee Corp. is fast-tracking a massive exploration and drilling program at Westhaven's Spences Bridge Gold Belt properties.

A new Shopify integration by Payfuture aims to solve a critical puzzle for global e-commerce: accepting local payments like UPI in India's booming market.

A UK spinout just raised £2M for an eye-drop that becomes a healing bandage on contact. This could disrupt a $12B market and offer hope for rare diseases.

With €33M in new funding, Cyllene Therapeutics is advancing a novel gene therapy using HSV-1 vectors. Could this be the one-shot cure for millions?

Big Digital Energy and 10NetZero are fast-tracking a massive AI datacenter in Texas. Is their innovative, power-first strategy the definitive blueprint?

Kavalan channels the historic 'Voyage Wine' with its new Solist Madeira Cask, a strategic play for the booming luxury travel retail market. Is this the future?

As Merit Medical preps its Q2 report, investors are watching more than numbers. Key acquisitions and product launches signal a deeper strategic shift.

Record rainfall has submerged parts of Canada's capital, revealing the stark vulnerability of our power grid and the immense challenge of building for a new climate.

While Mazda's premium CX-90 SUV shatters sales records, the company's overall Canadian sales are down nearly 14% year-to-date, a sign of deep market stress.

As AI's energy demand threatens to overwhelm grids, CleanAmps and Excelsior are building a U.S.-owned platform to merge compute and power infrastructure.

Sitemetric launches an agentic AI that not only monitors but autonomously fixes issues on job sites, signaling a major shift from passive data to active AI.

As a heat dome scorches the U.S., one company's 'awareness' campaign reveals a complex strategy of market opportunism and careful liability management.

A new study for CRENESSITY could revolutionize care for infants with classic congenital adrenal hyperplasia, shifting the treatment paradigm and solidifying market leadership.

Saia's patriotic NASCAR sponsorship is no mere holiday gesture. It's a calculated, high-stakes play for brand dominance in the competitive logistics sector.

Record trading volumes and a 67% jump in margin loans show IBKR isn't just growing, it's dominating the active trader space. What do these numbers signal?